Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Respiratory Distress Syndrome Revenue 1.4 Market Analysis by Type 1.4.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Poractant Alfa 1.4.3 Beractant 1.4.4 Calfactant 1.4.5 Others 1.5 Market by Application 1.5.1 Global Respiratory Distress Syndrome Market Share by Application: 2020 VS 2026 1.5.2 Very Preterm Infants 1.5.3 Moderate to Late Preterm Infants 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Respiratory Distress Syndrome Market Perspective (2015-2026) 2.2 Respiratory Distress Syndrome Growth Trends by Regions 2.2.1 Respiratory Distress Syndrome Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Respiratory Distress Syndrome Historic Market Share by Regions (2015-2020) 2.2.3 Respiratory Distress Syndrome Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Respiratory Distress Syndrome Market Growth Strategy 2.3.6 Primary Interviews with Key Respiratory Distress Syndrome Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Respiratory Distress Syndrome Players by Market Size 3.1.1 Global Top Respiratory Distress Syndrome Players by Revenue (2015-2020) 3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by Players (2015-2020) 3.1.3 Global Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Respiratory Distress Syndrome Market Concentration Ratio 3.2.1 Global Respiratory Distress Syndrome Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Respiratory Distress Syndrome Revenue in 2019 3.3 Respiratory Distress Syndrome Key Players Head office and Area Served 3.4 Key Players Respiratory Distress Syndrome Product Solution and Service 3.5 Date of Enter into Respiratory Distress Syndrome Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Respiratory Distress Syndrome Historic Market Size by Type (2015-2020) 4.2 Global Respiratory Distress Syndrome Forecasted Market Size by Type (2021-2026) 5 Respiratory Distress Syndrome Breakdown Data by Application (2015-2026) 5.1 Global Respiratory Distress Syndrome Market Size by Application (2015-2020) 5.2 Global Respiratory Distress Syndrome Forecasted Market Size by Application (2021-2026) 6 Europe 6.1 Europe Respiratory Distress Syndrome Market Size (2015-2020) 6.2 Respiratory Distress Syndrome Key Players in Europe (2019-2020) 6.3 Europe Respiratory Distress Syndrome Market Size by Type (2015-2020) 6.4 Europe Respiratory Distress Syndrome Market Size by Application (2015-2020) 7 China 7.1 China Respiratory Distress Syndrome Market Size (2015-2020) 7.2 Respiratory Distress Syndrome Key Players in China (2019-2020) 7.3 China Respiratory Distress Syndrome Market Size by Type (2015-2020) 7.4 China Respiratory Distress Syndrome Market Size by Application (2015-2020) 8 Iran 8.1 Iran Respiratory Distress Syndrome Market Size (2015-2020) 8.2 Respiratory Distress Syndrome Key Players in Iran (2019-2020) 8.3 Iran Respiratory Distress Syndrome Market Size by Type (2015-2020) 8.4 Iran Respiratory Distress Syndrome Market Size by Application (2015-2020) 9 United States 9.1 United States Respiratory Distress Syndrome Market Size (2015-2020) 9.2 Respiratory Distress Syndrome Key Players in United States (2019-2020) 9.3 United States Respiratory Distress Syndrome Market Size by Type (2015-2020) 9.4 United States Respiratory Distress Syndrome Market Size by Application (2015-2020) 10 Korea 10.1 Korea Respiratory Distress Syndrome Market Size (2015-2020) 10.2 Respiratory Distress Syndrome Key Players in Korea (2019-2020) 10.3 Korea Respiratory Distress Syndrome Market Size by Type (2015-2020) 10.4 Korea Respiratory Distress Syndrome Market Size by Application (2015-2020) 11Key Players Profiles 11.1 Chiesi Farmaceutici 11.1.1 Chiesi Farmaceutici Company Details 11.1.2 Chiesi Farmaceutici Business Overview and Its Total Revenue 11.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Introduction 11.1.4 Chiesi Farmaceutici Revenue in Respiratory Distress Syndrome Business (2015-2020)) 11.1.5 Chiesi Farmaceutici Recent Development 11.2 CR-Double Crane 11.2.1 CR-Double Crane Company Details 11.2.2 CR-Double Crane Business Overview and Its Total Revenue 11.2.3 CR-Double Crane Respiratory Distress Syndrome Introduction 11.2.4 CR-Double Crane Revenue in Respiratory Distress Syndrome Business (2015-2020) 11.2.5 CR-Double Crane Recent Development 11.3 ONY Biotech 11.3.1 ONY Biotech Company Details 11.3.2 ONY Biotech Business Overview and Its Total Revenue 11.3.3 ONY Biotech Respiratory Distress Syndrome Introduction 11.3.4 ONY Biotech Revenue in Respiratory Distress Syndrome Business (2015-2020) 11.3.5 ONY Biotech Recent Development 11.4 AbbVie 11.4.1 AbbVie Company Details 11.4.2 AbbVie Business Overview and Its Total Revenue 11.4.3 AbbVie Respiratory Distress Syndrome Introduction 11.4.4 AbbVie Revenue in Respiratory Distress Syndrome Business (2015-2020) 11.4.5 AbbVie Recent Development 11.5 Yuhan Corporation 11.5.1 Yuhan Corporation Company Details 11.5.2 Yuhan Corporation Business Overview and Its Total Revenue 11.5.3 Yuhan Corporation Respiratory Distress Syndrome Introduction 11.5.4 Yuhan Corporation Revenue in Respiratory Distress Syndrome Business (2015-2020) 11.5.5 Yuhan Corporation Recent Development 11.6 JW Pharmaceuticals 11.6.1 JW Pharmaceuticals Company Details 11.6.2 JW Pharmaceuticals Business Overview and Its Total Revenue 11.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Introduction 11.6.4 JW Pharmaceuticals Revenue in Respiratory Distress Syndrome Business (2015-2020) 11.6.5 JW Pharmaceuticals Recent Development 11.7 Noargen 11.7.1 Noargen Company Details 11.7.2 Noargen Business Overview and Its Total Revenue 11.7.3 Noargen Respiratory Distress Syndrome Introduction 11.7.4 Noargen Revenue in Respiratory Distress Syndrome Business (2015-2020) 11.7.5 Noargen Recent Development 12Analyst's Viewpoints/Conclusions 13Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Respiratory Distress Syndrome Key Market Segments Table 2. Key Players Covered: Ranking by Respiratory Distress Syndrome Revenue Table 3. Ranking of Global Top Respiratory Distress Syndrome Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Respiratory Distress Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Poractant Alfa Table 6. Key Players of Beractant Table 7. Key Players of Calfactant Table 8. Key Players of Others Table 9. Global Respiratory Distress Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Respiratory Distress Syndrome Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Respiratory Distress Syndrome Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Respiratory Distress Syndrome Market Share by Regions (2015-2020) Table 13. Global Respiratory Distress Syndrome Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Respiratory Distress Syndrome Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Respiratory Distress Syndrome Market Growth Strategy Table 19. Main Points Interviewed from Key Respiratory Distress Syndrome Players Table 20. Global Respiratory Distress Syndrome Revenue by Players (2015-2020) (Million US$) Table 21. Global Respiratory Distress Syndrome Market Share by Players (2015-2020) Table 22. Global Top Respiratory Distress Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Distress Syndrome as of 2019) Table 23. Global Respiratory Distress Syndrome by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Respiratory Distress Syndrome Product Solution and Service Table 26. Date of Enter into Respiratory Distress Syndrome Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Respiratory Distress Syndrome Market Size by Type (2015-2020) (Million US$) Table 29. Global Respiratory Distress Syndrome Market Size Share by Type (2015-2020) Table 30. Global Respiratory Distress Syndrome Revenue Market Share by Type (2021-2026) Table 31. Global Respiratory Distress Syndrome Market Size Share by Application (2015-2020) Table 32. Global Respiratory Distress Syndrome Market Size by Application (2015-2020) (Million US$) Table 33. Global Respiratory Distress Syndrome Market Size Share by Application (2021-2026) Table 34. Europe Key Players Respiratory Distress Syndrome Revenue (2019-2020) (Million US$) Table 35. Europe Key Players Respiratory Distress Syndrome Market Share (2019-2020) Table 36. Europe Respiratory Distress Syndrome Market Size by Type (2015-2020) (Million US$) Table 37. Europe Respiratory Distress Syndrome Market Share by Type (2015-2020) Table 38. Europe Respiratory Distress Syndrome Market Size by Application (2015-2020) (Million US$) Table 39. Europe Respiratory Distress Syndrome Market Share by Application (2015-2020) Table 40. China Key Players Respiratory Distress Syndrome Revenue (2019-2020) (Million US$) Table 41. China Key Players Respiratory Distress Syndrome Market Share (2019-2020) Table 42. China Respiratory Distress Syndrome Market Size by Type (2015-2020) (Million US$) Table 43. China Respiratory Distress Syndrome Market Share by Type (2015-2020) Table 44. China Respiratory Distress Syndrome Market Size by Application (2015-2020) (Million US$) Table 45. China Respiratory Distress Syndrome Market Share by Application (2015-2020) Table 46. Iran Key Players Respiratory Distress Syndrome Revenue (2019-2020) (Million US$) Table 47. Iran Key Players Respiratory Distress Syndrome Market Share (2019-2020) Table 48. Iran Respiratory Distress Syndrome Market Size by Type (2015-2020) (Million US$) Table 49. Iran Respiratory Distress Syndrome Market Share by Type (2015-2020) Table 50. Iran Respiratory Distress Syndrome Market Size by Application (2015-2020) (Million US$) Table 51. Iran Respiratory Distress Syndrome Market Share by Application (2015-2020) Table 52. United States Key Players Respiratory Distress Syndrome Revenue (2019-2020) (Million US$) Table 53. United States Key Players Respiratory Distress Syndrome Market Share (2019-2020) Table 54. United States Respiratory Distress Syndrome Market Size by Type (2015-2020) (Million US$) Table 55. United States Respiratory Distress Syndrome Market Share by Type (2015-2020) Table 56. United States Respiratory Distress Syndrome Market Size by Application (2015-2020) (Million US$) Table 57. United States Respiratory Distress Syndrome Market Share by Application (2015-2020) Table 58. Korea Key Players Respiratory Distress Syndrome Revenue (2019-2020) (Million US$) Table 59. Korea Key Players Respiratory Distress Syndrome Market Share (2019-2020) Table 60. Korea Respiratory Distress Syndrome Market Size by Type (2015-2020) (Million US$) Table 61. Korea Respiratory Distress Syndrome Market Share by Type (2015-2020) Table 62. Korea Respiratory Distress Syndrome Market Size by Application (2015-2020) (Million US$) Table 63. Korea Respiratory Distress Syndrome Market Share by Application (2015-2020) Table 64. Chiesi Farmaceutici Company Details Table 65. Chiesi Farmaceutici Business Overview Table 66. Chiesi Farmaceutici Product Table 67. Chiesi Farmaceutici Revenue in Respiratory Distress Syndrome Business (2015-2020) (Million US$) Table 68. Chiesi Farmaceutici Recent Development Table 69. CR-Double Crane Company Details Table 70. CR-Double Crane Business Overview Table 71. CR-Double Crane Product Table 72. CR-Double Crane Revenue in Respiratory Distress Syndrome Business (2015-2020) (Million US$) Table 73. CR-Double Crane Recent Development Table 74. ONY Biotech Company Details Table 75. ONY Biotech Business Overview Table 76. ONY Biotech Product Table 77. ONY Biotech Revenue in Respiratory Distress Syndrome Business (2015-2020) (Million US$) Table 78. ONY Biotech Recent Development Table 79. AbbVie Company Details Table 80. AbbVie Business Overview Table 81. AbbVie Product Table 82. AbbVie Revenue in Respiratory Distress Syndrome Business (2015-2020) (Million US$) Table 83. AbbVie Recent Development Table 84. Yuhan Corporation Company Details Table 85. Yuhan Corporation Business Overview Table 86. Yuhan Corporation Product Table 87. Yuhan Corporation Revenue in Respiratory Distress Syndrome Business (2015-2020) (Million US$) Table 88. Yuhan Corporation Recent Development Table 89. JW Pharmaceuticals Company Details Table 90. JW Pharmaceuticals Business Overview Table 91. JW Pharmaceuticals Product Table 92. JW Pharmaceuticals Revenue in Respiratory Distress Syndrome Business (2015-2020) (Million US$) Table 93. JW Pharmaceuticals Recent Development Table 94. Noargen Company Details Table 95. Noargen Business Overview Table 96. Noargen Product Table 97. Noargen Revenue in Respiratory Distress Syndrome Business (2015-2020) (Million US$) Table 98. Noargen Recent Development Table 99. Research Programs/Design for This Report Table 100. Key Data Information from Secondary Sources Table 101. Key Data Information from Primary Sources List of Figures Figure 1. Global Respiratory Distress Syndrome Market Share by Type: 2020 VS 2026 Figure 2. Poractant Alfa Features Figure 3. Beractant Features Figure 4. Calfactant Features Figure 5. Others Features Figure 6. Global Respiratory Distress Syndrome Market Share by Application: 2020 VS 2026 Figure 7. Very Preterm Infants Case Studies Figure 8. Moderate to Late Preterm Infants Case Studies Figure 9. Others Case Studies Figure 10. Respiratory Distress Syndrome Report Years Considered Figure 11. Global Respiratory Distress Syndrome Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Respiratory Distress Syndrome Market Share by Regions: 2020 VS 2026 Figure 13. Global Respiratory Distress Syndrome Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Respiratory Distress Syndrome Market Share by Players in 2019 Figure 16. Global Top Respiratory Distress Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Distress Syndrome as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Respiratory Distress Syndrome Revenue in 2019 Figure 18. Europe Respiratory Distress Syndrome Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Respiratory Distress Syndrome Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Iran Respiratory Distress Syndrome Market Size YoY Growth (2015-2020) (Million US$) Figure 21. United States Respiratory Distress Syndrome Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Korea Respiratory Distress Syndrome Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Chiesi Farmaceutici Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Chiesi Farmaceutici Revenue Growth Rate in Respiratory Distress Syndrome Business (2015-2020) Figure 25. CR-Double Crane Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. CR-Double Crane Revenue Growth Rate in Respiratory Distress Syndrome Business (2015-2020) Figure 27. ONY Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. ONY Biotech Revenue Growth Rate in Respiratory Distress Syndrome Business (2015-2020) Figure 29. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. AbbVie Revenue Growth Rate in Respiratory Distress Syndrome Business (2015-2020) Figure 31. Yuhan Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Yuhan Corporation Revenue Growth Rate in Respiratory Distress Syndrome Business (2015-2020) Figure 33. JW Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. JW Pharmaceuticals Revenue Growth Rate in Respiratory Distress Syndrome Business (2015-2020) Figure 35. Noargen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Noargen Revenue Growth Rate in Respiratory Distress Syndrome Business (2015-2020) Figure 37. Bottom-up and Top-down Approaches for This Report Figure 38. Data Triangulation Figure 39. Key Executives Interviewed

Chiesi Farmaceutici CR-Double Crane ONY Biotech AbbVie Yuhan Corporation JW Pharmaceuticals Noargen